Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Evofem Biosciences Logo
Evofem Biosciences Growth Score
54
CB Rank
43710
Heat Score
59
Evofem is a biopharmaceutical company that offers women reproductive and contraceptive care products.
Acquired by
Aditxt Therapeutics Logo
Aditxt Therapeutics
Founded
obfuscation
PublicPost-IPO Equity San Diego, California, United States51-100 www.evofem.com
Biopharma
Health Care
Medical
Women's
Overview

Evofem Biosciences
Total Funding
obfuscation
Growth Score
54
Heat Score
59

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score54
-4 pts
in past quarter
Heat Score 59
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Evofem Biosciences

CB Rank
43710
Evofem is a biopharmaceutical company that offers women reproductive and contraceptive care products.
Acquired by
Aditxt Therapeutics Logo
Aditxt Therapeutics
Founded
obfuscation
PublicPost-IPO Equity San Diego, California, United States51-100 www.evofem.com
Biopharma
Health Care
Medical
Women's

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name EVOFEM BIOSCIENCES, INC.
Also Known As Neothetics
Operating Status Active
Stock Symbol  OTCQB:EVFM
Company Type For Profit
Founders  Saundra Pelletier
About the Company
Evofem is a biopharmaceutical company that offers women's reproductive and contraceptive care products. The company's first commercial product, Phexxi, is the first and only hormone-free, prescription vaginal gel approved in the United States to prevent pregnancy.
Phone Number (858)-550-1900
Contact Email info@evofem.com
Diversity Spotlight 
Women Founded
Women Led
Predictions & Insights

Growth Insight

See this Growth Insight
Evofem Biosciences is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Products & Services

Phexxi
A hormone-free, on-demand prescription contraceptive vaginal gel used to prevent pregnancy by maintaining vaginal pH levels.
SOLOSEC
SOLOSEC is an oral antibiotic granule formulation for single-dose treatment of bacterial vaginosis and trichomoniasis.

Research & Development

Evofem Biosciences is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 17
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Evofem Biosciences Logo
Post-IPO Equity - Evofem Biosciences
1
obfuscation
Aditxt TherapeuticsPost-IPO Equity
obfuscation
Post-IPO Equity - Evofem Biosciences Logo
Post-IPO Equity - Evofem Biosciences
1
obfuscation
Aditxt TherapeuticsPost-IPO Equity
obfuscation
Post-IPO Equity - Evofem Biosciences Logo
Post-IPO Equity - Evofem Biosciences
1
obfuscation
Aditxt TherapeuticsPost-IPO Equity
obfuscation
Post-IPO Equity - Evofem Biosciences Logo
Post-IPO Equity - Evofem Biosciences
1
obfuscation
Aditxt TherapeuticsPost-IPO Equity
obfuscation
Post-IPO Equity - Evofem Biosciences Logo
Post-IPO Equity - Evofem Biosciences
1
obfuscation
Aditxt TherapeuticsPost-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 17
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Evofem Biosciences Logo
Post-IPO Equity - Evofem Biosciences
1
obfuscation
Aditxt TherapeuticsPost-IPO Equity
obfuscation
Post-IPO Equity - Evofem Biosciences Logo
Post-IPO Equity - Evofem Biosciences
1
obfuscation
Aditxt TherapeuticsPost-IPO Equity
obfuscation
Post-IPO Equity - Evofem Biosciences Logo
Post-IPO Equity - Evofem Biosciences
1
obfuscation
Aditxt TherapeuticsPost-IPO Equity
obfuscation
Post-IPO Equity - Evofem Biosciences Logo
Post-IPO Equity - Evofem Biosciences
1
obfuscation
Aditxt TherapeuticsPost-IPO Equity
obfuscation
Post-IPO Equity - Evofem Biosciences Logo
Post-IPO Equity - Evofem Biosciences
1
obfuscation
Aditxt TherapeuticsPost-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Aditxt Therapeutics Logo
Aditxt Therapeutics
Yes
Post-IPO Equity - Evofem Biosciences Logo
Post-IPO Equity - Evofem Biosciences
—
Aditxt Therapeutics Logo
Aditxt Therapeutics
Yes
Post-IPO Equity - Evofem Biosciences Logo
Post-IPO Equity - Evofem Biosciences
—
Aditxt Therapeutics Logo
Aditxt Therapeutics
Yes
Post-IPO Equity - Evofem Biosciences Logo
Post-IPO Equity - Evofem Biosciences
—
Aditxt Therapeutics Logo
Aditxt Therapeutics
Yes
Post-IPO Equity - Evofem Biosciences Logo
Post-IPO Equity - Evofem Biosciences
—
Aditxt Therapeutics Logo
Aditxt Therapeutics
Yes
Post-IPO Equity - Evofem Biosciences Logo
Post-IPO Equity - Evofem Biosciences
—

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1

M&A Details

Evofem Biosciences was acquired by Aditxt Therapeutics on
obfuscation
.
Transaction Name 
Evofem Biosciences acquired by Aditxt Therapeutics Logo
Evofem Biosciences acquired by Aditxt Therapeutics
Acquired by 
Aditxt Therapeutics Logo
Aditxt Therapeutics
Announced Date 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 6 Board Members and Advisors 6 Contacts 67

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 28, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

449
-82.4%
 in past month

IT Spend

$1.3MThis year, Evofem Biosciences is projected to spend $1.3M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Base Currency Logo
Base Currency
100
TheStreet Logo
TheStreet
95
PayPal Holdings, Inc (PYPL) Logo
PayPal Holdings, Inc (PYPL)
93

Actively Used Products

22Evofem Biosciences uses 22 technology products and services including HTML5, Lightbox, and  Vimeo, according to G2 Stack.

Active Website Tech Count

53Evofem Biosciences is actively using 53 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and  SSL by Default.

Total IP

42The intellectual property of Evofem Biosciences includes 17 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Evofem Biosciences has registered 25 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Evofem Biosciences's headquarters? Evofem Biosciences is located in San Diego, California, United States.Who invested in Evofem Biosciences? Evofem Biosciences has 16 investors including Aditxt Therapeutics and  Keystone Capital.When was the last funding round for Evofem Biosciences? Evofem Biosciences closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Evofem Biosciences's competitors? Alternatives and possible competitors to Evofem Biosciences may include Vella Bioscience, Tabu, and  Playground.How much funding has Evofem Biosciences raised to date? Evofem Biosciences has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|